Latanoprost And Timolol Accord Healthcare (Timolol Maleate, Latanoprost)

Latanoprost and Timolol is indicated for the management of glaucoma and ocular hypertension, conditions characterized by elevated intra‑ocular pressure.

• Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow progression of optic nerve damage.
• Ocular hypertension: lowers intra‑ocular pressure to prevent development of glaucoma.
• Secondary open‑angle glaucoma: helps control pressure when caused by other ocular conditions.
• Pseudoexfoliative glaucoma: decreases intra‑ocular pressure to protect the optic nerve.

• Latanoprost, a prostaglandin analog, increases uveoscleral outflow of aqueous humor by remodeling the extracellular matrix of the ciliary body. Timolol maleate, a non‑selective beta‑adrenergic antagonist, reduces aqueous humor production through blockade of β‑receptors in the ciliary epithelium, together lowering intra‑ocular pressure.

Common Side Effects

• Eye irritation or burning sensation.
• Blurred vision shortly after instillation.
• Redness of the conjunctiva.
• Itching or mild allergic reaction on the ocular surface.

Serious or Rare Side Effects

• Severe allergic reaction with swelling of the eyelid or face.
• Marked bradycardia or systemic hypotension.
• Bronchospasm or worsening of asthma symptoms.
• Uveitis or intra‑ocular inflammation.

Before using Latanoprost and Timolol, consider the following precautions:

• Cardiovascular assessment: evaluate heart rate and blood pressure before initiating therapy.
• Respiratory evaluation: avoid use in patients with asthma or severe chronic obstructive pulmonary disease.
• Allergy screening: discontinue if signs of hypersensitivity such as rash or eye swelling appear.
• Ocular surface disease: use with caution in patients with severe dry eye or corneal disorders.
• Systemic beta‑blocker use: monitor for additive bradycardic effects when combined with oral beta‑blockers.
• Store at room temperature: keep the bottle tightly closed, protect from light and moisture.

Latanoprost and Timolol may interact with other medicines as follows:

Major Interactions (Avoid)

• Non‑selective systemic beta‑blockers (e.g., propranolol): may cause excessive bradycardia.
• Sympathomimetic ophthalmic agents (e.g., epinephrine): can antagonize the intra‑ocular pressure‑lowering effect.
• MAO inhibitors: may increase the risk of systemic hypotension when combined.

Moderate Interactions (Monitor Closely)

• Carbonic anhydrase inhibitor eye drops (e.g., dorzolamide): additive IOP‑lowering may require monitoring.
• Anticholinergic eye drops: may affect pupil size and ocular comfort.
• Systemic steroids: can reduce the efficacy of the prostaglandin component.